Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Goldtropfen-W is a homeopathic combination medicinal product developed by Weber & Weber Biologische Arzneimittel, traditionally used for the supportive treatment of cardiovascular conditions. The formulation is designed to address symptoms such as nervous heart complaints, circulatory weakness, and age-related decline in cardiac performance. It typically contains a synergistic blend of homeopathic dilutions, including *Crataegus* (Hawthorn), which is recognized for its cardiotonic properties and ability to improve coronary blood flow; *Cactus* (Queen of the Night), used to manage heart rhythm and chest tightness; and *Aurum chloratum natronatum* (Gold sodium chloride), intended to stabilize blood pressure and support overall heart function. As a biological medicine, it aims to stimulate the body's self-regulatory mechanisms to improve cardiovascular resilience.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Goldtropfen-W.